stallimycin has been researched along with Ovarian Neoplasms in 3 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, R | 1 |
| al-Said, NH | 1 |
| Sternbach, DL | 1 |
| Lown, JW | 2 |
| Marverti, G | 1 |
| Guaitoli, G | 1 |
| Ligabue, A | 1 |
| Frassineti, C | 1 |
| Monti, MG | 1 |
| Lombardi, P | 1 |
| Costi, MP | 1 |
| Sharma, SK | 1 |
| Morrissey, AT | 1 |
| Miller, GG | 1 |
| Gmeiner, WH | 1 |
3 other studies available for stallimycin and Ovarian Neoplasms
| Article | Year |
|---|---|
Camptothecin and minor-groove binder hybrid molecules: synthesis, inhibition of topoisomerase I, and anticancer cytotoxicity in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; DNA, Neoplas | 1997 |
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells.
Topics: Antineoplastic Agents; Base Sequence; Cell Line, Tumor; Cisplatin; Distamycins; DNA Primers; Drug Re | 2012 |
Design, synthesis, and intracellular localization of a fluorescently labeled DNA binding polyamide related to the antibiotic distamycin.
Topics: Antiviral Agents; Biological Transport; Distamycins; DNA; Drug Design; Female; Fluorescence; Humans; | 2001 |